Method of treating the chronic viral hepatitis C
The invention refers to medicine, namely to hepatology and is meant for treating the chronic viral hepatitis C.The method, according to the invention, consists in that it is administered 300...400 ml of ozonized 0.9% NaCl solution, comprising 4...5 mg/L of ozone, intravenously drop-by-drop within a...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; rum ; rus |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention refers to medicine, namely to hepatology and is meant for treating the chronic viral hepatitis C.The method, according to the invention, consists in that it is administered 300...400 ml of ozonized 0.9% NaCl solution, comprising 4...5 mg/L of ozone, intravenously drop-by-drop within a day for 10...12 sittings per course of treatment and concomitantly there are daily administered spasmolytics, amino acids and hepatoprotectors in common daily dose. After termination of the course of treatment during 5...6 months it is administered a hepatoprotector. At the same time, the treatment is carried out at least three years.
Invenţia se referă la medicină, şi anume la hepatologie şi este destinată pentru tratamentul hepatitei virale cronice C.Metoda, conform invenţiei, constă în aceea că se administrează 300 ... 400 ml soluţie de NaCl 0,9% ozonizată, care conţine 4 ... 5 mg/l ozon, intravenos în picături peste o zi câte 10...12 şedinţe la o serie şi concomitent zilnic se administrează spasmolitice, aminoacizi şi hepatoprotectori în doză zilnică obişnuită. După terminarea seriei în decurs de 5 ... 6 luni se administrează un hepatoprotector. Totodată, tratamentul se efectuează cel puţin trei ani.
Изобретение относится к медицине, а именно к гепатологии и предназначено для лечения хронического вирусного гепатита С.Метод, согласно изобретению, заключается в том, что вводят 300...400 мл озонированного 0,9% раствора NaCl, который содержит 4...5 мг/л озона, внутривенно капельно через день по 10...12 сеансов на курс и одновременно ежедневно вводят спазмолитики, аминокислоты и гепатопротекторы в обычной суточной дозе. После окончания курса в течение 5...6 месяцев вводят гепатопротектор. При этом лечение проводят не менее трёх лет. |
---|